Product review · Updated September 30, 2026
Kate Somerville EradiKate Mark Fading Gel review: two full lists remain different
The 2% acne active is clear, while two website ingredient names are absent from the posted-label narrative.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Kate Somerville’s EradiKate Acne Mark Fading Gel tells two connected product stories: acne treatment with salicylic acid 2%, and a manufacturer account of clearer-looking marks and a supported skin barrier. The complete website ingredient list gives those claims more context. It also raises a version question when compared with the posted US labeling record, whose inactive narrative omits two website names.
Both exact records were examined on September 30, 2026. They agree on the declared acne active and identify the fading gel, rather than its neighboring sulfur products. Their inactive declarations remain distinct. No package or formulation-change date was verified, and no underlying clinical study was examined to establish how the mark or barrier claims relate to individual outcomes.
In this article
A fading gel within the EradiKate range
The manufacturer calls the item EradiKate Acne Mark Fading Gel and presents it as a 2% salicylic-acid treatment. The page also displays neighboring EradiKate sulfur products. Those adjacent listings do not supply the active concentration, formula or evidence for the fading gel being reviewed. Product-range proximity is not ingredient equivalence. Exact manufacturer item.
The cream-versus-cleanser guide gives format distinctions a place in the comparison. Here, gel is a useful identity descriptor, not proof of a particular feel on every skin type. The review follows this named product without importing the roles or results of the other EradiKate items.
Acne purpose and acne-mark wording are separate
The website promotes smaller-looking post-acne marks and clearer-looking skin. The December 2025 label identifies salicylic acid 2% and an acne-treatment purpose, with uses concerning acne and new blemishes. Those are related descriptions, but they are not an examined demonstration that acne and mark endpoints were measured together. Manufacturer claims; Posted label.
A review can preserve both descriptions without treating one as proof of the other. The examined pages do not supply a full study report separating the outcomes or identifying a comparative result. The Clinique review offers another discussion of a product-specific endpoint rather than a substitute result for this gel. An acne-treatment purpose does not by itself define the size, color or persistence of a post-acne mark endpoint. The available record separates its labeled acne role from the broader appearance promise, leaving the full mark-assessment methods unexamined.
The website supplies a complete inactive narrative
The manufacturer separates its salicylic-acid active from a long inactive list. Among the declared names are niacinamide, glycerin, propanediol, two separately named Microcitrus fruit extracts and Lactobacillus ferment. This is a full narrative account of the advertised preparation, rather than only a selection of hero ingredients. Website declaration.
Those names do not reveal a measured percentage for every constituent or establish a personal comfort result. The ingredient-record guide provides further context for full lists and highlights. This review does not calculate an internal recipe or treat the presence of a named ferment as an independently tested barrier outcome.
Two website names are absent from the posted narrative
The December 1, 2025 posted label identifies NDC 72204-903 and the fading preparation as a gel. Its complete inactive narrative does not name propanediol or Microcitrus australasica fruit extract, both present in the website list. The different Microcitrus australis name remains in the posted narrative; the two plant names should not be silently treated as interchangeable. Label declaration; Website list.
This observation describes a record difference. It does not prove which list appears on a reader’s package or when a formula changed. Combining the lists would make a declaration unsupported by either source, so the discrepancy remains open. This is more than a capitalization difference: specific declared names are absent from one narrative. The observation still cannot identify the exact contents of an uninspected tube, and it should not be expanded into a finding that either document proves a manufacturing error.
Barrier and prebiotic language belongs to the seller
The product page attributes a healthy skin-barrier role to prebiotics and describes mark-fading benefits. These claims help explain the manufacturer’s intended story for the gel. The examined record does not attach a full finished-product barrier report that this review could evaluate alongside the complete declaration. Manufacturer account.
The Dermalogica serum review offers another reading about ingredient and comfort wording. That is not evidence that the products have a common tested benefit. Neither a familiar ingredient name nor an adjacent product’s marketing can close the missing report or establish what will happen to a particular person’s skin.
Rare Beauty Brands identifies the labeled preparation
The posted record names Rare Beauty Brands Inc as packager and supplies the EradiKate Acne Mark Fading identity, active, acne purpose and structured gel description. These fields tie the declaration to a specific submitted label. They do not turn the labeler’s name into a clinical credential or establish that the gel has received a product-specific efficacy review from this publication. December record.
Both the label and website also retain a warning about increased irritation or dryness with another topical acne medicine. The dry-skin guide provides broader context without selecting a combination or diagnosing an existing symptom.
The version difference is part of the finished-product story
The sources give a clear declared active and a less settled inactive-formula match. That combination is worth preserving: a review can identify this fading gel while acknowledging that the two full narratives differ. The disagreement does not justify assuming that the manufacturer’s comfort claims apply to every version or package. Product record; Label record.
Customer testimonials and an automated review summary on the manufacturer page were not treated as clinical evidence or firsthand experience. The remaining questions concern exact version identity and the missing underlying reports. A public product review can organize those records, but cannot supply a personal skin assessment or safety clearance.
Sources behind this reading
- Kate Somerville EradiKate Acne Mark Fading Gel: official product ↗US manufacturer product record · Checked September 30, 2026
- EradiKate Acne Mark Fading: December 2025 Rare Beauty Brands label ↗Brand-linked manufacturer-submitted US OTC labeling record · Checked September 30, 2026